297 related articles for article (PubMed ID: 33094634)
1. Circulating MicroRNAs as Diagnostic Biomarkers of Clinical Cognitive Impairment: A Meta-Analysis.
Shi D; Han M; Liu W; Tao J; Chen L
Am J Alzheimers Dis Other Demen; 2020; 35():1533317520951686. PubMed ID: 33094634
[TBL] [Abstract][Full Text] [Related]
2. Circulating MicroRNAs as Potential Diagnostic Biomarkers for Diabetic Retinopathy: A Meta-Analysis.
Ma L; Wen Y; Li Z; Wu N; Wang Q
Front Endocrinol (Lausanne); 2022; 13():929924. PubMed ID: 35898469
[TBL] [Abstract][Full Text] [Related]
3. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Ritchie C; Smailagic N; Noel-Storr AH; Ukoumunne O; Ladds EC; Martin S
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010803. PubMed ID: 28328043
[TBL] [Abstract][Full Text] [Related]
4. (11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Zhang S; Smailagic N; Hyde C; Noel-Storr AH; Takwoingi Y; McShane R; Feng J
Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD010386. PubMed ID: 25052054
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of circulating microRNAs for osteosarcoma in Asian populations: a meta-analysis.
Wang X; Ning Y; Yang L; Liu H; Wu C; Wang S; Guo X
Clin Exp Med; 2017 May; 17(2):175-183. PubMed ID: 27106278
[TBL] [Abstract][Full Text] [Related]
6. The Diagnostic Value of Exosome-Derived Biomarkers in Alzheimer's Disease and Mild Cognitive Impairment: A Meta-Analysis.
Xing W; Gao W; Lv X; Xu X; Zhang Z; Yan J; Mao G; Bu Z
Front Aging Neurosci; 2021; 13():637218. PubMed ID: 33732139
[No Abstract] [Full Text] [Related]
7. The potential diagnostic accuracy of circulating microRNAs for Alzheimer's disease: A meta-analysis.
Zhang WT; Zhang GX; Gao SS
Neurologia (Engl Ed); 2024 Mar; 39(2):147-159. PubMed ID: 38460993
[TBL] [Abstract][Full Text] [Related]
8. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
9. Performance of Validated MicroRNA Biomarkers for Alzheimer's Disease in Mild Cognitive Impairment.
Sandau US; Wiedrick JT; Smith SJ; McFarland TJ; Lusardi TA; Lind B; Harrington CA; Lapidus JA; Galasko DR; Quinn JF; Saugstad JA
J Alzheimers Dis; 2020; 78(1):245-263. PubMed ID: 32955460
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of circulating microRNAs in thyroid carcinoma: A systematic review and meta-analysis.
Xu SL; Tian YY; Zhou Y; Liu LQ
Clin Endocrinol (Oxf); 2020 Oct; 93(4):489-498. PubMed ID: 32379941
[TBL] [Abstract][Full Text] [Related]
11. The potential diagnostic accuracy of circulating microRNAs for prostate cancer: A meta-analysis.
Zhang WT; Zhang GX; Zhao RZ; Gao SS
Actas Urol Esp (Engl Ed); 2022 Apr; 46(3):138-149. PubMed ID: 35260368
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of circulating microRNAs for esophageal cancer: a meta-analysis based on Asian data.
Zhang WT; Wang YJ; Zhang GX; Zhang YH; Gao SS
Rev Esp Enferm Dig; 2023 Sep; 115(9):504-514. PubMed ID: 35040334
[TBL] [Abstract][Full Text] [Related]
13. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Smailagic N; Vacante M; Hyde C; Martin S; Ukoumunne O; Sachpekidis C
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010632. PubMed ID: 25629415
[TBL] [Abstract][Full Text] [Related]
14. Predictive accuracy of amyloid imaging for progression from mild cognitive impairment to Alzheimer disease with different lengths of follow-up: a meta-analysis. [Corrected].
Ma Y; Zhang S; Li J; Zheng DM; Guo Y; Feng J; Ren WD
Medicine (Baltimore); 2014 Dec; 93(27):e150. PubMed ID: 25501055
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs as diagnostic biomarkers for melanoma: a systematic review and meta-analysis.
Wu N; Sun H; Sun Q; Zhang F; Ma L; Hu Y; Cong X
BMC Cancer; 2023 May; 23(1):414. PubMed ID: 37158840
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs as Potential Biomarkers for the Diagnosis of Endometrial Cancer: a Meta-Analysis.
Gao J; Fan YZ; Gao SS; Zhang WT
Reprod Sci; 2023 Feb; 30(2):464-472. PubMed ID: 35764858
[TBL] [Abstract][Full Text] [Related]
17. 18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Bonfill Cosp X; Flicker L
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012216. PubMed ID: 29164603
[TBL] [Abstract][Full Text] [Related]
18. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
Zhang L; Cao D; Tang L; Sun C; Hu Y
Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
[TBL] [Abstract][Full Text] [Related]
19. Beyond CSF and Neuroimaging Assessment: Evaluating Plasma miR-145-5p as a Potential Biomarker for Mild Cognitive Impairment and Alzheimer's Disease.
Wen Q; Wittens MMJ; Engelborghs S; van Herwijnen MHM; Tsamou M; Roggen E; Smeets B; Krauskopf J; Briedé JJ
ACS Chem Neurosci; 2024 Mar; 15(5):1042-1054. PubMed ID: 38407050
[TBL] [Abstract][Full Text] [Related]
20. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012884. PubMed ID: 29164602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
